Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

Ami N. Shah(The University of Texas MD Anderson Cancer Center), Justin M. Summy(The University of Texas MD Anderson Cancer Center), Jing Zhang(The University of Texas MD Anderson Cancer Center), Serk In Park(The University of Texas MD Anderson Cancer Center), Nila U. Parikh(The University of Texas MD Anderson Cancer Center), Gary E. Gallick(The University of Texas MD Anderson Cancer Center)
Annals of Surgical Oncology
October 1, 2007
10.1245/s10434-007-9583-5
Cited by 432

Abstract

Related Papers

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al.|Journal of Clinical Oncology|1997|5.9k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Jing Yang, Sendurai A. Mani, Joana Liu Donaher et al.|Cell|2004|3.8k
Identification of Pancreatic Cancer Stem Cells
Chenwei Li, David G. Heidt, Piero Dalerba et al.|Cancer Research|2007|3.4k
Scatter factor/hepatocyte growth factor is essential for liver development
Claudia Schmidt, Friedhelm Bladt, Stefanie Goedecke et al.|Nature|1995|1.4k
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Friedhelm Bladt, Dieter Riethmacher, Stefan Isenmann et al.|Nature|1995|1.3k